Fluorescent probing of the ligand-binding ability of blood plasma in the acute-phase response

Clinical and Experimental Medicine

Volumn 2, Issue 3, 2002, Pages 147-155

  Ivanov, A I ^a   Gavrilov, V B ^b   Furmanchuk, D A ^c   Aleinikova, O V ^c   Konev, S V ^b   Kaler, G V ^b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^c Belarusian Research Center for Pediatric Oncology and Hematology   (Belarus)

^d Axiom Biotechnologies Inc   (United States)

Author keywords

Fluorescent dyes; Leukemia; Lipoproteins; Sepsis; Serum albumin; 1 Acid glycoprotein

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; CARRIER PROTEIN; FLUORESCENT DYE; HIGH DENSITY LIPOPROTEIN; HUMAN ALBUMIN; LOW DENSITY LIPOPROTEIN; NILE RED; OROSOMUCOID; QUINALDINE RED; UNCLASSIFIED DRUG; 1-ANILINO-8-NAPHTHALENESULFONATE; LIGAND; LIPOPROTEIN; OXAZINE DERIVATIVE; QUINALDINE DERIVATIVE; SERUM ALBUMIN;

ACUTE PHASE RESPONSE; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE; HUMAN; LEUKEMIA; LIGAND BINDING; MALE; PLASMA; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTEIN TRANSPORT; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SPECTROFLUOROMETRY; BLOOD; CHILD; IN VITRO STUDY; KINETICS; METABOLISM;

ACUTE-PHASE REACTION; ANILINO NAPHTHALENESULFONATES; CHILD; FEMALE; FLUORESCENT DYES; HUMANS; KINETICS; LEUKEMIA; LIGANDS; LIPOPROTEINS; MALE; OXAZINES; PLASMA; QUINALDINES; SEPSIS; SERUM ALBUMIN; SHOCK, SEPTIC; SPECTROMETRY, FLUORESCENCE;

EID: 0036452189     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380200021     Document Type: Article

References (37)

1. Kushner I, Rzewnicki DL (1997) The acute phase response. In: Mackowiak PA (ed) Fever: Basic Mechanisms and Management. Lippincott-Raven, Philadelphia, pp 117-145
2. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
3. Trautwein C, Boker K, Manns MP (1994) Hepatocyte and immune system: Acute phase reaction as a contribution to early defence mechanisms. Gut 35:1163-1166
4. Pannen BHJ, Robotham JL (1995) The acute-phase response. New Horiz 3:183-197
5. Moshage H (1997) Cytokines and the hepatic acute phase response. J Pathol 181:257-266
6. Moore DF, Rosenfeld MR, Gribbon PM, Winlove CP, Tsai CM (1997) Alpha-1-acid (AAG, orosomucoid) glycoprotein: Interaction with bacterial lipopolysaccharide and protection from sepsis. Inflammation 21:69-82
7. Tobias PS, McAdam KPWJ, Ulevich RJ (1982) Interaction of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A. J Immunol 128:1420-1427
8. Read TE, Harris HW, Grunfeld C, Feingold KP, Kane JP, Rapp JH (1993) The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J 14:125-129
9. Schlichting E, Aspelin T, Lyberg T (1996) Interaction of endotoxin with human blood cells and serum proteins. Scand J Clin Invest 56:167-176
10. Meijer DKF, Sluijs P van der (1989) Covalent and noncovalent protein binding of drugs: implication for hepatic clearance, storage, and cell-specific drug delivery. Pharm Res 6:105-117
11. Herve F, Urien S, Albengres E, Duche JC, Tillement J-P (1994) Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clin Pharmacokinet 26:44-58
12. Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50:693-703
13. Kragh-Hansen U (1990) Structure and ligand binding properties of human serum albumin. Dan Med Bull 37:57-84
14. 1-acid glycoprotein in health and disease. Pharmacol Rev 40:1-48
15. Tokui T, Kuroiwa C, Muramatsu S, Tokui Y, Sasagawa K, Ikeda T, Komai T (1995) Plasma lipoproteins as targeting carriers to tumour tissues after administration of a lipophilic agent to mice. Biopharm Drug Dispos 16:91-103
16. Wasan KM, Cassidy SM (1998) Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J Pharm Sci 87:411-424
17. Echizen H, Saima S, Umeda N, Ishizaki T (1987) Altered protein binding of disopyramide in plasma from patients with cancer and with inflammatory disease. Ther Drug Monit 9:272-278
18. 1-acid glyco-protein (AGP). Br J Clin Pharmacol 27:257-261
19. Gomez E, Martinez-Jorda R, Suarez E, Garrido MJ, Calvo R (1995) Altered methadone analgesia due to changes in plasma protein binding: Role of the route of administration. Gen Pharmacol 26:1273-1276
20. Stewart C, Pieper J, Arbuck S, Evans W (1989) Altered protein binding of etoposide in patients with cancer. Clin Pharmacol Ther 45:49-55
21. Petros WP, Rodman JH, Relling MV, Christensen M, Pui CH, Rivera GK, Evans WE (1992) Variability in teniposide plasma protein binding is correlated with serum albumin concentrations. Pharmacotherapy 12:273-277
22. McKindley DS, Boucher BA, Hess MM, Rodman JH, Feler C, Fabian TC (1997) Effect of acute phase response on phenytoin metabolism in neurotrauma patients. J Clin Pharmacol 37:129-139
23. Brown MB, Edmonts TE, Miller JN, Riley DP, Seare NJ (1993) Novel instrumentation and biomedical application of very near infrared fluorescence. Analyst 118:407-410
24. Epps DE, Raub TJ, Kezdy FJ (1995) A general, wide-range spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin. Anal Biochem 227:342-350
25. Altamentova SM, Shaklai N, Arav R, Miller YI (1998) A fluorescence method for estimation of toxemia: Binding capacity of lipoproteins and albumin in plasma. Clin Chim Acta 271:133-149
26. Vasileva R, Jakab M, Hasko F (1981) Application of ion-exchange chromatography for the production of human serum albumin. J Chromatogr 216:279-284
27. Schumaker VN, Pupione DL (1986) Sequential flotation centrifugation. Methods Enzymol 128:155-169
28. Doumas BT, Watson WA, Biggs HG (1971) Albumin standards and the measurement of serum albumin with Bromocresol green. Clin Chim Acta 31:87-96
29. Freifelder D (1976) Physical biochemistry. WH Freeman, San Francisco
30. 1-acid glycoprotein interaction. Biol Pharm Bull 16:926-929
31. 1-acid glycoprotein in serum using Quinaldine red. Pharm Res 11:566-570
32. Takikawa H, Sekiya Y, Yamanaka M, Sugiyama Y (1995) Binding of lithocholate and its glucuronide and sulphate by human serum albumin. Biochim Biophys Acta 1244:277-282
33. Greenspan P, Flowler SD (1985) Spectrofluorometric studies of the lipid probe, Nile red. J Lipid Res 26:781-789
34. Knobler H, Fainaru M, Sklan D (1987) Single-stage evaluation of serum lipoproteins by gel permeation using a specific fluorescent lipid probe. J Chromatogr 421:136-140
35. Peters T Jr (1996) All About Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, San Diego
36. Yu LC, Kuvibidila S, Ducos R, Warrier RP (1994) Nutritional status of children with leukemia. Med Pediatr Oncol 22:73-77
37. Farrell GC (1987) Drug metabolism in extrahepatic diseases. Pharmacol Ther 35:375-404